Takeda Pharmaceutical Company Limited Expected Future Minimum Sublease Payments Receivable Under Noncancellable Subleases Classified As Operating Lease
Takeda Pharmaceutical Company Limited (TKPHF) had Expected Future Minimum Sublease Payments Receivable Under Noncancellable Subleases Classified As Operating Lease of JPY 13.14 billion as of 2019-03-31, per its 20-F filed 2019-06-27.
Discontinued › Notes › Leases
ifrs-full:ExpectedFutureMinimumSubleasePaymentsReceivableUnderNoncancellableSubleasesClassifiedAsOperatingLease · last filed 2019-06-27
- 2019-03-31: Expected Future Minimum Sublease Payments Receivable Under Noncancellable Subleases Classified As Operating Lease 13.14B JPY.
- 2018-03-31: Expected Future Minimum Sublease Payments Receivable Under Noncancellable Subleases Classified As Operating Lease 34.48B JPY.
| Period end | Expected Future Minimum Sublease Payments Receivable Under Noncancellable Subleases Classified As Operating Lease |
|---|---|
| 2019-03-31 | 13.14B JPY 20-F · filed 2019-06-27 |
| 2018-03-31 | 34.48B JPY 20-F · filed 2019-06-27 |